Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Difurazone

    • Product Name Difurazone
    • Alias Furacin
    • Einecs 205-274-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    325323

    Name Difurazone
    Chemical Formula C12H8N4O6
    Molecular Weight 304.22 g/mol
    Appearance Yellow crystalline powder
    Cas Number 587-90-6
    Solubility Slightly soluble in water
    Usage Antibacterial agent, mainly in veterinary medicine
    Mechanism Of Action Inhibits bacterial enzyme systems
    Melting Point 241-245°C
    Atc Code D08AF07
    Synonyms Furacilin difurazone, Finifurazone
    Stability Stable under recommended storage conditions

    As an accredited Difurazone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Difurazone is supplied in a white, opaque, 100-gram plastic bottle with a tamper-evident screw cap and detailed labeling.
    Shipping Difurazone should be shipped in tightly sealed containers, protected from light and moisture. It must be handled according to hazardous material regulations, with appropriate labeling. During transport, maintain stable temperature and avoid extreme conditions. Ensure compliance with local, national, and international shipping guidelines for chemicals to prevent contamination or accidental exposure.
    Storage Difurazone should be stored in a tightly closed container, away from direct sunlight, heat, and moisture. Keep the chemical in a cool, dry, and well-ventilated area, separated from incompatible substances and ignition sources. Ensure the storage area is secure and access is restricted to qualified personnel. Always follow local regulations and safety guidelines for chemical storage.
    Application of Difurazone

    Applications of Difurazone in Industrial Manufacturing

    Difurazone, an established synthetic antibacterial agent, serves specialized roles in targeted industrial segments. As an original manufacturer, we support strict quality control and regulatory traceability, supplying global clients engaged in regulated manufacturing processes. Below, we provide a detailed breakdown of real downstream application fields, aligned with industrial standards and production requirements worldwide.

    1. Aquaculture Antibiotic Formulation

    Leading aquaculture producers formulate antibacterial veterinary drugs with difurazone to control specific bacterial diseases in high-value fish species, including aquacultured salmon and carp. The raw material typically enters premix manufacturing, where formulation scientists adjust inclusion rates based on pathogen profiles and fish species, prioritizing both efficacy and residue compliance. Final products must undergo batch QC, stability assessment, and validation for residue limits prior to market release.

    Industry compliance standards

    • China Veterinary Pharmacopoeia (2020 Edition), specific to aquatic pharmaceuticals
    • European Commission Regulation (EU) No 2019/6 for veterinary medicinal products
    • Good Manufacturing Practice (GMP) for Veterinary Medicines (Chinese MoA Standard NY/T 788)
    • Maximum Residue Limits (MRLs) as published by national regulators (e.g., Japan, China, FAO Codex)

    Typical usage ratio

    • 0.05%–0.5% by weight in formulated fish feed premix
    • Adjustment based on target species, water conditions, and sensitivity of local pathogen isolates, with maximum levels strictly controlled by feed labeling regulations

    Downstream process integration

    • Added during wet or dry mixing of medicated feed
    • Dosed into pre-weighed carrier matrices before blending
    • Heat exposure minimized during pelletizing to preserve activity

    Final product types

    • Commercial medicated fish feeds for disease outbreak control
    • Veterinary marketed premix packets for aquaculture farms
    • Bulk solution or powder for large-scale pond dosing

    2. Livestock and Poultry Disease Control Agents

    Major animal husbandry operations integrate difurazone in premixed veterinary preparations to aid disease management in pigs and poultry, especially for enteric infections where conventional agents cannot be used due to resistance. Product development teams utilize validated blends and manufacturing lines with careful in-process QC to ensure uniform distribution and effective bioavailability. All finished batches undergo residue level analyses and strict discharge documentation before export or distribution.

    Industry compliance standards

    • United States Code of Federal Regulations (21 CFR Part 558, New Animal Drugs for Use in Animal Feeds)
    • China Veterinary Drug Administration Regulations
    • European Pharmacopoeia monographs (where use authorized)
    • GMP for Veterinary Pharmaceutical Production (EU/China/US)

    Typical usage ratio

    • 0.025%–0.1% (w/w) in feed premix
    • May vary with disease severity, animal age, and dietary energy content; professional prescription and risk assessments required

    Downstream process integration

    • Incorporated into veterinary drug premixes at controlled temperature before extrusion
    • Laboratory dissolution and dispersibility tests performed before pilot-scale production
    • Residue monitoring conducted for all final feed lots

    Final product types

    • Medicated animal and poultry feed
    • Oral suspension sachets for farm administration
    • Direct-feed microencapsulated veterinary additives

    3. Research Reagents for Bacterial Growth Inhibition Studies

    Scientific research institutions and veterinary laboratories procure pharmaceutical-grade difurazone to develop, characterize, and validate microbiological assays that trace resistance trends in livestock pathogens. The substance is used in serial dilution and agar diffusion tests, with exact-weight assay preparation and validated analytical references. Documentation and lot-to-lot traceability remain critical to all laboratory workflows, supporting both public and private sector research projects.

    Industry compliance standards

    • Good Laboratory Practice (OECD GLP, 21 CFR Part 58)
    • ISO/IEC 17025 for laboratory testing and calibration
    • ASTM E2315 for microbial reduction efficacy assays
    • Pharmacopoeial references for laboratory chemicals (e.g., USP Reagent Standards)

    Typical usage ratio

    • 5–100 μg/mL in laboratory agar or broth, tailored to research protocol
    • Dilution range selected to match expected bacterial sensitivity patterns and experimental endpoints

    Downstream process integration

    • Weighed and dissolved aseptically before addition to assay media
    • Spiked into positive control wells for BSL-2 and BSL-3 bacterial challenge studies
    • Aliquoted directly for zone-of-inhibition or MIC testing

    Final product types

    • Bacterial growth inhibition assay kits
    • Standard reference solutions for laboratory use
    • Agricultural research test panels

    4. Active Pharmaceutical Ingredient (API) for Veterinary Formulation

    GMP-compliant veterinary pharmaceutical plants source highly purified difurazone as an API for finished dosage forms directed at companion animals and food-producing species, ensuring batch uniformity and process reproducibility. Manufacturing employs validated granulation and blending systems to avoid cross-contamination, with product release contingent on passing identity, assay, and impurity tests. All production and export adhere to up-to-date international registration files and technical dossiers for regulated veterinary products.

    Industry compliance standards

    • Veterinary Pharmacopoeia of the People’s Republic of China
    • Good Manufacturing Practice (GMP) for Active Pharmaceutical Ingredients (ICH Q7)
    • VICH GL9 Good Manufacturing Practice for APIs
    • Country-specific Drug Master File (DMF) requirements

    Typical usage ratio

    • 2–10 mg/kg body weight in veterinary tablets or oral suspensions
    • Manufactured strength and dosing per veterinary prescription information and region-specific product registrations

    Downstream process integration

    • Metered into tablet pressing or oral suspension blending under HEPA-filtered facilities
    • In-process controls for weight variation and content uniformity
    • Release testing for each batch aligned with finished pharmaceutical specifications

    Final product types

    • Prescription veterinary tablets
    • Liquid oral veterinary dosage forms
    • API exports for regional compounding or contract manufacturing
    Free Quote

    Competitive Difurazone prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Difurazone: Advancing Veterinary Medicine with Purpose and Precision

    A Manufacturer’s Perspective on Crafting Difurazone

    Manufacturing Difurazone brings a sense of responsibility. The compound does not often appear in mass-market news, but for people working with horses and those in the veterinary supply chain, its name carries heavy weight. I’ve spent years on the production floors and in R&D labs, refining every batch to meet industry demands without compromise. My team and I make every effort to ensure each shipment goes out consistent, pure, and steady—because animals, their owners, and veterinarians rely on it going right the first time.

    From Synthesis to Finished Product

    Difurazone’s journey begins in our reactors. The core of its structure, 5-nitro-2-furaldehyde semicarbazone, forms the backbone of its performance. We handle its production with care, maintaining strict humidity, temperature, and pressure controls during each step. Any variation in these parameters can shift the compound’s color, texture, or stability, risking the end result. We don’t cut corners. Technicians double-check key stages—filtering, recrystallization, drying, and milling. What works on a small lab scale needs thoughtful adjustment at factory volumes. Our process balances chemistry with hands-on control.

    Technical Profile and Physical Qualities

    Our facility produces Difurazone as a yellow crystalline powder, with a typical particle size below 150 microns. This texture optimizes its use in ointments and topical suspensions. Moisture can be an issue for some pharmaceutical raw materials; we’ve optimized our drying under reduced pressure to keep water content consistently under 1.5 percent. Safety and consistency stay in the foreground, with materials packed in triple-layered, high-barrier bags to keep out light, oxygen, and moisture.

    Practical Use in Veterinary Applications

    Most people see finished ointments on store shelves, but as the manufacturer, I see how veterinarians and formulators rely on precise Difurazone properties. The compound comes into play in treating horses’ skin infections—especially in “sweat” ointments designed for legs, hocks, and hooves. By disrupting bacterial growth at the wound surface, Difurazone gives inflammation a chance to recede and healthy tissue to return. Formulators look for easy dispersion in their base—paraffin, lanolin, or petroleum jelly. If our product clumps or holds excess water, blending gets tricky and ointment stability drops. Years of feedback from compounding pharmacies have improved our approaches.

    Protecting Efficacy Through Quality Control

    Making sterile or semi-sterile products from active ingredients gives few second chances. We run each lot through identity confirmation (by IR spectroscopy) and monitor impurities below the strictest pharmacopeial thresholds. Content assays, conducted by HPLC, verify ingredient strength within one percent of label claim—an industry standard that takes vigilance to maintain. Oxidative degradation or cross-contamination can slip by unnoticed in less scrupulous production settings. We uphold a zero-tolerance rule: suspect lots never reach our warehouse, let alone our customers.

    How Difurazone Stands Apart

    Antimicrobials in veterinary use cover a crowded field, so what makes Difurazone a mainstay in so many barns and clinics? Its nitrofuran base brings broad-spectrum activity, working against gram-positive and gram-negative strains. Polymyxin, neomycin, and bacitracin all carry their own profiles, but Difurazone stands out by keeping local tissue irritation low—an important point when treating deep or stubborn wounds in horses. Consistent reports from the field reflect this difference. After a rough day treating abscesses and open sores, veterinarians lean toward ointments that offer strong bacterial inhibition without stinging or macerating the skin. That’s where our Difurazone makes its mark.

    Addressing Manufacturing Hazards and Stewardship

    Producing nitrofuran compounds requires vigilance. Difurazone’s manufacturing intermediates carry risks for those handling them, so training and gear matter. Production lines feature closed systems, air monitoring, and spill containment zones to limit operator exposure. Wastewater leaves our plant only after neutralization and multi-stage filtration. We adopted process modifications to decrease byproduct formation, not only for safety but also to reduce environmental impact. Our workers understand the importance of compliance, not just for occupational health but for the welfare of receiving communities and water tables downstream.

    Documented Results and Scientific Background

    Publications in veterinary journals discuss nitrofuran ointments’ outcomes for equine injuries. Difurazone, in particular, ranks high for persistent or chronic cases, such as granulomatous wounds. Comparative studies show it maintains activity longer than many common alternatives, even in the face of exudate or mild contamination. Reports coming in from field veterinarians often reflect what we see in our own data—wounds close up faster, granulation tissue forms with fewer setbacks, and post-treatment complications dip lower than those with polymyxin or silver-based creams. People who work daily in equine care see and remember those differences.

    Regulatory Compliance and Documentation

    Regulators expect proof at every turn, and we maintain full traceability from raw material sourcing to customer delivery. Audit trails record every kilogram entering production, every operator’s batch log, every instrument calibration. Each label, whether for export to Europe or domestic veterinary use, shows batch, expiry, and complete documentation matching compendial requirements. Customers no longer accept vague assurances—they want certificates with every order. Our laboratory issues analyses that don’t just tick boxes; they provide a window into our process and ethics.

    Meeting User Needs in Diverse Settings

    Nothing replaces listening to veterinarians and compounding pharmacists. They have told us where ordinary nitrofuran products fall short: poor spreadability, uneven solubility, weird odors, or limited shelf life. We tweaked our synthesis steps, tested alternative drying methods, and sampled hundreds of stabilizers. These improvements transformed how our Difurazone integrates into compounded ointments and gels—reducing precipitation, keeping a pleasant application texture, and holding potency through real-world shipping conditions. We ship worldwide, so temperature swings or long storage times can’t be allowed to sap product quality. Our goal is straightforward: people using our Difurazone shouldn’t have to think twice about whether it will work as expected.

    How We Address Ethical and Practical Limitations

    Difurazone, like many antimicrobials, draws scrutiny over resistance patterns and potential misuse. Our stance is clear—responsible use means focusing on targeted therapy, not routine or prophylactic application. We collaborate with academic partners and animal health organizations to provide guidance on differential use and monitor any shifts in local resistance. Deviating from best practices not only risks animal health but can undermine the trust that veterinarians and regulators have granted over the years. We keep batch size flexible, scaling up or down to match genuine demand, rather than pushing inventories through aggressive sales tactics.

    Why Consistency Matters More Than Ever

    Consistency doesn’t just mean smoother logistics. Horse owners and trainers counting on rapid wound closure don’t want surprises. If we let production parameters slip or raw material quality slide, that confidence erodes quickly. Our most critical feedback arrives not from sales reports but from end users—the trainers, breeders, and equine hospitals who call us directly. We encourage those calls, and respond to concerns by adjusting specifications, retraining staff, or changing packaging as needed. This readiness to face feedback head-on sets us apart from manufacturers who lose touch with their supply chain or customer base.

    Looking Ahead: Innovations and Adaptations

    Demand for improvements never stops. We’ve invested in pilot reactors to test greener synthesis routes and purification methods that use fewer solvents and less energy. Our R&D group explores new stabilizers and microencapsulation approaches, hoping these tweaks can further extend shelf life or make mixing with bases even easier. Several veterinary groups have asked for powdered forms with guaranteed flow properties to suit modern compounding robots—an area we’re actively investigating after seeing how time-consuming manual blending can be in larger clinics.

    Comparing Difurazone to Alternatives

    We respect our competitors for the challenges they face, but Difurazone’s profile still earns it a favored place in the equine market. Silver sulfadiazine offers powerful antibacterial activity but often leads to dermal dryness and delays in epithelialization. Neomycin, though effective, causes hypersensitivity reactions in sensitive horses more often; veterinarians coping with unknown allergies don’t want to gamble in critical recovery periods. Even new-generation topical antimicrobials struggle with balancing robust action and low toxicity. Difurazone’s moderate spectrum and high tolerance set a benchmark everyone notices. As a manufacturer, these differences drive our product development and encourage investment in process improvements each year.

    Addressing Market Misconceptions

    We hear misconceptions that Difurazone is interchangeable with any nitrofuran or that regulations have largely pushed its use to the sidelines. While food chain restrictions limit systemic nitrofuran use in livestock, topical application in equine medicine still shows clear benefits—especially for non-food-producing horses. Our responsibility includes articulating this distinction clearly to distributors and professional users, helping them comply with regulations and avoid any risk to riders, handlers, and the wider community.

    Supply Chain Resilience and Transparency

    Markets shift fast, especially when export conditions or raw material prices jump unexpectedly. We keep several months of key intermediates in secure storage, and our supplier agreements specify detailed quality standards—including third-party testing before acceptance to prevent contaminant or impurity issues. Where sourcing pressures mount, we talk candidly to customers, offering alternative lot reservations, split deliveries, or samples for pre-approval. People who buy from a manufacturer want more than just product—they want proactive communication when something threatens their business or care routines. That’s never lost on us, and we build partnerships, not just sales channels, as a result.

    Designing for Care: Packaging Improvements

    Topical actives experience hazards most casual users don’t see. Exposure to light and moisture chips away at potency over time. Early on, we used standard polybags, but field complaints about discoloration or caking after long storage forced us to rethink everything. Now, each lot leaves our site in UV-blocking, triple-layered pouches with vacuum sealing. Large veterinary compounding operations have commented on the difference this change makes—less clumping, longer shelf life, and fewer lost batches. These incremental improvements make our product a better bet for people at every stage of use.

    Ethics in Action: Transparent Testing and Product Stewardship

    Being a manufacturer means the buck stops with you. We maintain a policy of transparency for all released batches—making our test results available to customers who request them, and participating in third-party quality audits. By opening our doors and records, we promote trust not only with end users but with regulators and auditors, too. If a batch falls short, we don’t hide it or push it to less demanding markets. Instead, we hold the lot, investigate the source, and report results honestly. In over two decades, this integrity has led more long-term relationships than any pricing strategy ever could.

    Veterinary Partnerships and Real-World Experience

    Our technical support line fields questions daily—ranging from optimal incorporation techniques in ointment manufacturing to compatibility with other active agents. We take those calls seriously, routing feedback to production and R&D, not just logging them away. If a veterinarian notes a blending issue or unexpected reaction, we assign a chemist to explore and answer with specifics, not platitudes. Working with veterinary schools, we send sampling kits and technical data so students can see firsthand how reliable Difurazone performs compared to generics or alternatives. In our view, this kind of engagement builds informed customers and keeps our standards high.

    Support Through Complexity: Navigating Global Regulations

    Difurazone’s use patterns vary country to country, which can complicate registration, shipping, and labeling. Our regulatory affairs team coordinates closely with authorities in each jurisdiction, providing dossiers and stability data on request. This engagement pays off when importers encounter new requirements—because they know they can call us and get answers, not silence. It’s not always easy or quick, but customers recognize this value each time they need technical assistance or regulatory clarification.

    Continual Process Improvement and Worker Expertise

    Our production workers bring decades of experience; they notice the faintest shift in reaction odor, crystal habit, or powder density. While automation speeds up some steps, keen human eyes and skilled hands still define our quality edge. We run annual retraining toward safety, process knowledge, and emerging best practices. With every change—whether a new filtration setup or more efficient reactor—we hold team briefings to explain, train, and gather feedback. Our staff’s relationship to the product matches the pride our customers feel when applying or prescribing our Difurazone ointment.

    Listening, Adapting, and Innovating

    Innovation rarely comes from laboratories alone. It bubbles up from the recurrent frustrations or surprising wins veterinarians share with us. Requests for easier-dispensing powders, more distinct batch markings, or extended shelf lives have all sparked initiatives within our walls. We track such improvements not just by cost saved but by field results—the faster wound healing, improved client satisfaction, or smoother pharmacy operations that follow. Our role isn’t just making chemicals; it’s supporting real people and real animals in pressing care situations.

    The Foundation and Future of Difurazone Manufacturing

    Every lot of Difurazone that leaves our facility stands as proof of our standards and values. We know its users demand more than standard efficacy—they require confidence, predictability, and reliability under unpredictable conditions. While we continue to refine chemistry and logistics, what truly sets our approach apart is the commitment to knowledge sharing, responsiveness, and rigorous consistency. In an era marked by uncertainty in supply chains and shifting regulatory expectations, that commitment lets us hold our ground, serve our customers, and elevate standards within veterinary medicine.